DNA Brands, Inc.
DNAX
$0.0001
$0.000.00%
| 09/30/2019 | 06/30/2019 | ||||
|---|---|---|---|---|---|
| Revenue | -6.94% | 1,700.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.94% | 1,700.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -6.94% | 1,700.00% | |||
| SG&A Expenses | 174.13% | -59.77% | |||
| Depreciation & Amortization | 360.00% | -44.44% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 178.28% | -59.72% | |||
| Operating Income | -239.45% | 69.55% | |||
| Income Before Tax | -788.99% | 69.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -788.99% | 69.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -788.99% | 69.55% | |||
| EBIT | -239.45% | 69.55% | |||
| EBITDA | -233.02% | 69.59% | |||
| EPS Basic | -539.81% | 96.60% | |||
| Normalized Basic EPS | -538.76% | 96.60% | |||
| EPS Diluted | -539.81% | 96.60% | |||
| Normalized Diluted EPS | -538.76% | 96.60% | |||
| Average Basic Shares Outstanding | 38.85% | 797.46% | |||
| Average Diluted Shares Outstanding | 38.85% | 797.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
